For patients with metastatic castration-sensitive prostate cancer (mCSPC) with homologous recombination repair (HRR) gene ...
Physicians and patient advocacy groups are rallying behind a renewed legislative effort in Congress to amend what they claim ...
Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...
Asianet Newsable on MSN
Drug Combo Cuts Progression Risk in Aggressive Prostate Cancer, Study Finds
A new study shows that adding niraparib to standard prostate cancer treatment slows disease progression by up to 50% in men ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
I am a healthy 69-year-old female. I walk every day and belong to an exercise group that I attend twice a week. I’m writing ...
Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous ...
WKRG Mobile on MSN
Medical Moment: Arthritis and Management with USA Health’s Dr. Price Sessums, M.D.
USA Health’s Dr. Price Sessums, M.D., joined WKRG News 5 to share how to manage the different types of arthritis. In the ...
The biotechs will assess a combination of two drugs against HER2-positive breast cancer. Elsewhere, Merck unveiled the latest piece of its more than $70 billion domestic manufacturing investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback